Showing results (671-680 of 2,106) with videos related to
Sort By:
Pageof 211
CNS Drugs|May 21, 2009
Utility of atypical antipsychotics in the treatment of resistant unipolar depressionCharles DeBattista, Jessica HawkinsCNS Drugs|May 21, 2009
Lisdexamfetamine dimesylate: in attention-deficit hyperactivity disorder in adultsJuliane Weber, M Asif A SiddiquiCNS Drugs|May 21, 2009
Mirtazapine: a review of its use in major depression and other psychiatric disordersKatherine F Croom, Caroline M Perry, Greg L PloskerCNS Drugs|October 23, 2009
Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: final results from an open-label, observational, multicentre studyJohn M Wild, Catherine Chiron, Hyosook Ahn, et al.CNS Drugs|October 23, 2009
Experience with intravenous levetiracetam in status epilepticus: a retrospective case seriesGonzalo Gámez-Leyva, José Luis Aristín, Emilio Fernández, et al.CNS Drugs|May 28, 2017
Achieving Smoking Cessation in Individuals with Schizophrenia: Special ConsiderationsCorinne Cather, Gladys N Pachas, Kristina M Cieslak, et al.CNS Drugs|May 21, 2017
Impact of Muscarinic M3 Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled StudyYen-Hao Tran, Catharina C M Schuiling-Veninga, Jorieke E H Bergman, et al.CNS Drugs|June 10, 2017
Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic ModelMarjie L Hard, Richard J Mills, Brian M Sadler, et al.CNS Drugs|March 3, 2010
The safety and tolerability of newer antiepileptic drugs in children and adolescentsDean P Sarco, Blaise F D BourgeoisPageof 211